AZTA — Azenta Inc. stock price and chart

AZTA

$35.73+2.55%

as of close, Oct 20, 2026

☾ AH $35.73 +2.55%

Azenta Inc.Stock · HealthcareRussell 2000 · 0.03% of IWMUS Stock Market · 0.001% of VTIRussell 3000 · 0.001% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDEEEEEEEEEEE

20162019202120242026

20.030.040.050.060.070.080.090.0100.0110.0120.0010.0M20.0M$35.73

2026-10-20

Price$35.73

MA20$28.64

MA50$29.42

Vol4.0M

What would $1,000 invested in AZTA be worth today? →

AZTA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $35.73
YTD price return: +7.43%
YTD total return: +7.43%
Next earnings: Nov 20, 2026
Market cap: 1.6B2016-12 1.2B2026-10 1.6B+32.9% over the window
Enterprise value: 1.1B
Shares outstanding: 43.8M2016-06 68.6M2026-06 43.8M-36.2% over the window
52W low: $15.93
52W high: $46.41
From 52W high: -23.01%
From 52W low: +124.29%
52W range: 65%

Volume

Rel volume: 0.67×
30D volume: 1.1M
30D $ vol: 40.4M

Fundamentals

Sales (ttm): 613.8M2016-06 548.5M2026-06 613.8M+11.9% over the window
Sales/share: $14.012016-06 $7.992026-06 $14.01+75.3% over the window
EPS (ttm): -$2.672016-06 -$1.072026-06 -$2.67+149.4% over the window
FCF (ttm): 9.9M2016-06 18.8M2026-06 9.9M-47.3% over the window
FCF/share: $0.232016-06 $0.272026-06 $0.23-17.4% over the window
Book value/share: $34.472016-06 $7.912026-06 $34.47+335.7% over the window
Net margin: -20.02%2016-06 -13.4%2026-06 -20.0%+49.5% over the window
ROE: -8.14%2016-06 -13.5%2026-06 -8.1%-39.8% over the window
ROA: -6.55%2016-06 -10.8%2026-06 -6.6%-39.2% over the window
Current ratio: 2.502016-06 2.402026-06 2.50+4.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +4.89%2025-06-30 → 2026-06-30585.2M → 613.8M (+4.9% total)-0.88%2023-06-30 → 2026-06-30630.3M → 613.8M (-2.6% total)+4.82%2021-06-30 → 2026-06-30485M → 613.8M (+26.6% total)+1.13%2016-06-30 → 2026-06-30548.5M → 613.8M (+11.9% total)
FCF: -81.13%2025-06-30 → 2026-06-3052.3M → 9.9M (-81.1% total)n/a-40.25%2021-06-30 → 2026-06-30129.7M → 9.9M (-92.4% total)-6.21%2016-06-30 → 2026-06-3018.8M → 9.9M (-47.3% total)
Shares: -4.43%2025-06-30 → 2026-06-3045.8M → 43.8M (-4.4% total)-10.03%2023-06-30 → 2026-06-3060.2M → 43.8M (-27.2% total)-10.03%2021-06-30 → 2026-06-3074.3M → 43.8M (-41.0% total)-4.39%2016-06-30 → 2026-06-3068.6M → 43.8M (-36.2% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +9.75%2025-06-30 → 2026-06-30$12.77 → $14.01 (+9.7% total)+10.17%2023-06-30 → 2026-06-30$10.48 → $14.01 (+33.7% total)+16.51%2021-06-30 → 2026-06-30$6.53 → $14.01 (+114.6% total)+5.78%2016-06-30 → 2026-06-30$7.99 → $14.01 (+75.3% total)
FCF/share: -80.26%2025-06-30 → 2026-06-30$1.14 → $0.23 (-80.2% total)n/a-33.59%2021-06-30 → 2026-06-30$1.75 → $0.23 (-87.1% total)-1.90%2016-06-30 → 2026-06-30$0.27 → $0.23 (-17.4% total)
Book value/share: -5.55%2025-06-30 → 2026-06-30$36.50 → $34.47 (-5.6% total)-8.69%2023-06-30 → 2026-06-30$45.28 → $34.47 (-23.9% total)+14.39%2021-06-30 → 2026-06-30$17.60 → $34.47 (+95.8% total)+15.86%2016-06-30 → 2026-06-30$7.91 → $34.47 (+335.7% total)
Dividend/share: +0.00%2021-09-30 → 2022-09-30$0.40 → $0.40 (+0.0% total)+0.00%2019-09-30 → 2022-09-30$0.40 → $0.40 (+0.0% total)+0.00%2017-09-30 → 2022-09-30$0.40 → $0.40 (+0.0% total)n/a
Price: +13.19%2025-10-20 → 2026-10-20$31.57 → $35.73 (+13.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-10.36%2023-10-20 → 2026-10-20$49.61 → $35.73 (-28.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-19.61%2021-10-20 → 2026-10-20$106.40 → $35.73 (-66.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.39%2016-10-19 → 2026-10-20$13.29 → $35.73 (+168.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +13.19%2025-10-20 → 2026-10-20$31.57 → $35.73 (+13.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-10.36%2023-10-20 → 2026-10-20$49.61 → $35.73 (-28.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-19.60%2021-10-20 → 2026-10-20$106.31 → $35.73 (-66.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+11.05%2016-10-19 → 2026-10-20$12.53 → $35.73 (+185.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -13.4×2016-12 -16.962026-10 -12.74-24.9% over the window
Fwd P/E: 63.1×
P/S (ttm)Market cap ÷ TTM revenue.: 2.6×2016-12 2.712026-10 2.55-6.1% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.0×2016-12 2.132026-10 1.04-51.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 158.4×2016-12 44.132026-10 158.41+259.0% over the window
EV/Sales (ttm): 1.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 0.63%2016-09 2.3%2026-06 0.9%-61.0% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 43.8M ÷ 45.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 4.43%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.43%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.43%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($47.7M) ÷ today's market cap ($1.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 3.04%2016-09 -0.2%2026-06 4.3%-2759.8% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $47.7M + TTM dividends $0) ÷ today's market cap ($1.6B). Same caveat as the cash buyback yield.: 3.04%2016-09 2.2%2026-06 4.3%+96.0% over the window

Vs own 10Y history

P/E: 1st
P/S: 14th
P/B: 20th
P/FCF: 90th

Bar = where today’s multiple sits in AZTA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.55%

-5.65%

+7.49%

+36.06%

YTD

+7.43%

+13.18%

-66.42%

Financial statements

Open full AZTA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

AZTA — Azenta Inc. price, chart and key statistics